People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster ...

What started out as a “tiny little brown line” on one woman’s fingernail led to a rare, potentially life-threatening medical condition, one that she’s now trying to help ...